Dr. Nakul Singh, MD

Dr. Singh practices at Retinal Consultants Medical Group in Sacramento, California.

Dr. Singh's NPI, 1649776535, was assigned on April 1, 2018. Dr. Singh graduated from Cleveland Medical College, Homeopathic in 2018. Dr. Singh holds California license A195329.

Dr. Singh's primary practice is Retinal Consultants Medical Group, at 3 Park Center Dr, Sacramento, CA 95825 in Sacramento County. The practice phone is (209) 549-8444.

Dr. Singh's primary practice is Retinal Consultants Medical Group in Sacramento, California. Dr. Singh is also affiliated with Dignity Health - Mercy General Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Singh to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singh practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Singh's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Singh is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Singh's licenses on file in 3 states: California, Maryland and Massachusetts.

Dmand AI lists eyelid inflammation, laser destruction of retinal or choroid lesions, retinal occlusion, surgical retina and vitreous procedures and vitreous eye degeneration among the conditions Dr. Singh treats.

CMS data shows 1,706 Medicare services from Dr. Singh across 17 procedure codes in 2024, for 255 Medicare patients. Medicare paid $112,061 for them.

CMS counts 255 Medicare patients who saw Dr. Singh in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Singh's median patient age at 65, with 53% women.

In 2024, Dr. Singh wrote 338 Medicare Part D claims for 135 patients. 62% of them were for generic drugs. CMS names the drug for 299 of them, across 7 drugs with 11 or more claims each, at $8,225 in total drug cost. In 2023, CMS named 476 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Singh for performance year 2024, reported as part of a group. Dr. Singh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 34 papers to Dr. Singh, published from 2014 to 2024. 2015 was the busiest year, with 6. The most frequent topics are Melanoma, Uveal Neoplasms and Uveal Melanoma. Dr. Singh has published most often in Ocul Oncol Pathol. Dr. Singh's most frequent co-authors are Hassan Aziz, MD, Claudine Bellerive, MD and Jose J. Echegaray, MD.

CMS Open Payments shows 25 general payments to Dr. Singh from 8 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. TissueTech, Inc. paid the most, $346.

Dr. Singh graduated from Cleveland Medical College, Homeopathic in 2018.

Dr. Singh is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.